Avistone Wins China Approval For First C-Met Inhibitor In Glioblastoma

 
• By Dexter Jie Yan
  
glioblastoma
Avistone's vebreltinib found effective for rare subtype of glioblastoma in China Phase II/III trial • Source: Shutterstock

More from China

More from Focus On Asia